EMIS · Emmis Acquisition Corp.
Substantial doubt about the company's ability to continue as a going concern.
“Management believes that the Company has sufficient funds to meet its working capital needs through the mandatory liquidation date. However, because the Company is required to complete its initial Business Combination or obtain an extension of the Combination Period by March 26, 2027, which falls within one year from the date these condensed financial statements are issued, or otherwise cease operations and liquidate, management has concluded that substantial doubt exists about the Company's ability to continue as a going concern. The accompanying condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 6, 2026
Price & Indicators
The closing range uses available history since Oct 22, 2025; less than a full year is stored.
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EMIS
this stock
Emmis Acquisition Corp.
|
$161.70M | +3.0% | — | — | 0.0% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
CCXI
Churchill Capital Corp XI
|
$686.22M | — | — | — | 6.7% |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$647.37M | +2.7% | — | — | 0.2% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$602.01M | +2.7% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EMIS | +0.3% | +1.5% | — | +0.3% | +3.0% |
| SPY | +0.3% | +0.6% | +16.7% | +0.8% | +13.4% |
| vs SPY | +0.0% | +0.9% | — | -0.5% | -10.4% |